White paper on designing a risk evaluation and mitigation strategies (REMS) system to optimize the balance of patient access, medication safety, and impact on the health care system

The Journey of the American Society for Pain Management Nursing Into Advocacy and Governmental Affairs

“…One of our early issues was the proposed Food and Drug Administrations (FDA) Risk Evaluation Mitigation Strategy (REMS) for opioid medications ( American Pharmacists Association, 2009 ). We provided oral and written testimony to FDA meetings outlining our position.…”